Caitlin Cronin
Stock Analyst at Canaccord Genuity
(0.92)
# 2029
Out of 5,328 analysts
26
Total ratings
42.86%
Success rate
2.55%
Average return
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
SNN Smith & Nephew | Maintains: Hold | 27 28 | 28.34 | -1.2% | 2 | May 1, 2025 | |
INMD InMode | Maintains: Hold | 17 15 | 14.86 | 0.94% | 3 | Apr 29, 2025 | |
TELA TELA Bio | Maintains: Buy | 12 7 | 1 | 600% | 4 | Mar 21, 2025 | |
BVS Bioventus | Maintains: Buy | 15 15 | 7.35 | 104.08% | 1 | Mar 17, 2025 | |
AXGN Axogen | Maintains: Strong Buy | 22 26 | 16.63 | 56.34% | 4 | Feb 26, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 64 67 | 38.7 | 73.13% | 3 | Feb 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 3 4 | 2.69 | 48.7% | 2 | Nov 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 20 20 | 11.24 | 77.94% | 3 | Aug 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | 130 | 102.14 | 27.28% | 1 | Feb 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 73 75 | 34.75 | 115.83% | 1 | Feb 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 79 | 71.57 | 10.38% | 1 | Feb 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 270 12 | 8 | 50% | 1 | Nov 14, 2023 |